The N-terminal domain of HARS is a novel NRP2 ligand and can regulate NRP2-dependent macrophage function

American Association for Cancer Research, 2019

« ATYR1923 Reduces Neutrophil Infiltration in an Acute Lipopolysaccharide (LPS) Lung Injury Model

ATYR1923 Modulates the Inflammatory Response in Experimental Models of Interstitial Lung Disease »

© 2007 - 2024 aTyr Pharma. Legal Privacy Policy